Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral Sequences

3 Jul 2024

Abstract excerpt

Coronavirus infectious disease 2019 (COVID-19), caused by severe acute respiratory virus type 2 (SARS-CoV-2), has caused a global public health crisis. As an RNA virus, the high gene mutability of SARS-CoV-2 poses significant challenges to the development of broad-spectrum vaccines and antiviral therapeutics. There remains a lack of specific therapeutics directly targeting SARS-CoV-2. With the ability to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39066234
DOI: 10.3390/v16071072

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral SequencesPMID 39066234Read ↗

Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based deliverySemantic proximity Read ↗

In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2Semantic proximity Read ↗

Design and Delivery of Therapeutic siRNAs: Application to MERS-CoronavirusSemantic proximity Read ↗

Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIVSemantic proximity Read ↗

A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replicationSemantic proximity Read ↗

Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infectionSemantic proximity Read ↗

Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader SequenceSemantic proximity Read ↗

A small interfering RNA (siRNA) database for SARS-CoV-2Semantic proximity Read ↗

Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral InhibitorsSemantic proximity Read ↗

An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.